Partnership to provide oncology portfolio with a translational platform
Mitra Biotech and Glenmark Pharmaceuticals have partnered to advance research on Glenmark’s immuno-oncology treatments using Mitra’s platform.
Mitra Biotech and Glenmark Pharmaceuticals have partnered to advance research on Glenmark’s immuno-oncology treatments using Mitra’s platform.
A study demonstrated that IV immunogloubin may be able to help treat a subset of individuals with autism spectrum disorder.
Novo Nordisk will restructure its R&D operations through the increased investment made possible by laying off 400 members of staff.